Skip to content
Events

Details

The science behind XLEAP-SBSᵀᴹ Chemistry​

In this webinar Pietro Gatti, Associate Director & Future Tech Strategy Lead is joined by the Illumina science team to showcase the research and development that went into building the new XLEAP-SBS Chemistry.

Complete the form to access the On Demand webinar

Your email address is never shared with third parties.

Date & Time
20 Mar 2024
Location
Europe
Affiliation
Associate Director & Future Tech Strategy Lead, Illumina
Presenter
Pietro Gatti
Topic
Cancer research, Cellular & molecular biology, Genetic & rare diseases
Watch Now
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2024 Illumina, Inc. All rights reserved.